VTT-originating startup Proteins.1 launches to bring PCR-like amplification and simplicity to omics
VTT Press releases vttresearch.com
Listen to this summary
New Finnish deep-tech company aims to make ultra-early disease detection possible through single-molecule protein amplification, enabling the identification of molecular warning signals long before disease becomes clinically visible. The technology has the potential to shift healthcare from reactive treatment to true prevention, extend healthy lifespans, and reduce the global burden of cancer, neurological disorders, and cardiovascular disease.
More ways to use this
Open on another device
Scan to open this page. Your saved notes and account access are not included.
Tenable One Adversary View brings Claude Mythos’ adversarial reasoning to your environment